Clinical Trial Update: Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study assessing gepotidacin in subjects with varying renal function versus normal function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Bacterial

Drugs mentioned

• Gepotidacin (gepotidacin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED | Results posted: 2018-11-20